Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study in The Lancet concluded the vaccine is 80% effective at preventing hospitalization due to co...
Flu symptoms tend to pop up 1 to 4 days after you're exposed to the virus. They'll last around 5 to 7 days. But if you've had the flu vaccine, they may last for a shorter amount of time and be less severe. RSV vs COVID ...
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and ...
GSK’s vaccine generated £709mn of sales in the third quarter of 2023. Analysts have predicted that it hit the $1bn milestone at which drugs become “blockbusters” in the final quarter of the year. GSK will disclose sales figures when it reports full-year results on Wednesday. UnderEmma...
While there’s no vaccine for infants and young children yet, it might be available this fall if approved by the FDA. “A maternal vaccine is promising and is in the process of being considered for approval,” Dr. Maldonado said.
FDA advisers back Pfizer’s maternal RSV vaccine after voicing safety concerns. BMJ 381, 1187 (2023). Article PubMed Google Scholar McLellan, J. S. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr. Opin. Virol. 11, 70–75 (2015). Article CAS PubMed Pub...
Blue Lake Biotechnology, Inc. today announced preliminary data from the first two cohorts of a Phase 1/2a clinical trial studying BLB201, the company’s investigational vaccine against severe respiratory syncytial virus (RSV) disease.
While most RSV infections go away on their own, Dr. Nirma Vadlamudi, the first co-author of the study and a vaccine researcher at the BC Children’s Hospital, said the prevalence of cases among infants can be cause for concern. “The main issue is that children who are admitted ...
Antibodies mediate humoral immune responses and play key roles in the defense of viral infection by the recognition, neutralization, and elimination of viruses from the circulation. For the prevention of respiratory syncytial virus (RSV) infection, the n